Concepedia

Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin–vindesine

Johan Vansteenkiste, J. Vandebroek, K Nackaerts, P. Weynants, Y. Valcke, D. Verresen, Roger Devogelaere, Steven Mariën, Yves Humblet, Nancy Dams

Annals of Oncology · 2001 · 103 citations · 25 references

Open access

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyCombination ChemotherapyLung CancerMalignant NeoplasmsDurable Clinical ResponseGemcitabine-based TherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment

References

25

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

Medicine, Oncology, Pharmacotherapy +16

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

Colin B. Begg · JAMA · 1996 · 3.4K citations

Pharmacy, Internal Medicine, Clinical Data Management +14

Improving the Quality of Reporting of Randomized Controlled Trials

Colin B. Begg · JAMA · 1996 · 3.1K citations

Public Health, Internal Medicine, Clinical Epidemiology +12